Investors who lost money on Pacira BioSciences, Inc. should contact Levi & Korsinsky about an ongoing investigation - PCRX
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Pacira BioSciences, Inc. (NASDAQ:PCRX) for potential violations of federal securities laws. This follows a press release by Pacira on August 9, 2024, regarding the outcome of its patent infringement lawsuit against eVenus.
January 13, 2025 | 12:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Pacira BioSciences is under investigation by Levi & Korsinsky for potential federal securities law violations. This comes after their lawsuit against eVenus for patent infringement.
The investigation by Levi & Korsinsky into potential securities law violations could negatively impact investor sentiment and lead to short-term stock price declines. Legal issues often create uncertainty, which can result in selling pressure.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100